There is robust evidence to support the impact of real time CGM (continuous glucose monitoring) on improvements in diabetes outcome measures including A1C reduction, fewer hypoglycemic events, satisfaction and quality of life. CGM systems continue to evolve rapidly with software tweaks to the Libre system and new systems emerging including the recent Health Canada approved Dexcom G7. This session will support pharmacists to optimize health outcomes for people affected by diabetes through personalized use of CGM. Pharmacists will be able to identify who would benefit from access to which CGM system and recommend CGM appropriately. The basics of dispensing a new prescription for CGM will be reviewed, as well as actioning on follow-up opportunities to enhance care in a community pharmacy.

Sponsored by: Dexcom